Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

AMTI

The FlyCyclo Therapeutics closes AMT merger, cash runway extended into 2H

12M ago

AMTI

CYTH

PremiumThe Fly

Applied Molecular Transport trading resumes

1y ago

AMTI

PremiumThe Fly

Applied Molecular holders get 0.174 Cyclo shares in exchange for AMT share

1y ago

AMTI

CYTH

PremiumThe Fly

Cyclo Therapeutics, Applied Molecular Transport announce merger deal

1y ago

AMTI

CYTH

PremiumThe Fly

Applied Molecular Transport trading halted, news pending

1y ago

AMTI

PremiumThe FlyAllogene Therapeutics appoints Douglas as General Counsel

1y ago

ALLO

AMTI

Premium

Pre-Earnings

AMTI Upcoming Earnings Report: What to Expect?

1y ago

AMTI

Premium

Pre-Earnings

Is AMTI a Buy, Before Earnings?

2y ago

AMTI

PremiumThe Fly

Applied Molecular Transport downgraded to Neutral from Buy at Chardan

2y ago

AMTI

PremiumThe Fly

Applied Molecular Transport engages advisor to explore strategic alternatives

2y ago

AMTI

PremiumThe Fly

Applied Molecular Transport CEO Tahir Mahmood to leave in workforce reduction

2y ago

AMTI

PremiumThe Fly

Applied Molecular Transport reports Q4 EPS (58c), consensus (59c)

2y ago

AMTI

PremiumThe FlyApplied Molecular Transport presents additional data from FILLMORE trial

2y ago

AMTI

Applied Molecular Transport downgraded to Underperform from Hold at Jefferies

Premium

The Fly

Applied Molecular Transport downgraded to Underperform from Hold at Jefferies

2y ago

AMTI

BofA double downgrades Applied Molecular with upside catalysts removed

Premium

The Fly

BofA double downgrades Applied Molecular with upside catalysts removed

2y ago

AMTI

PremiumThe Fly

Applied Molecular Transport downgraded to Underperform from Buy at BofA

2y ago

AMTI

PremiumThe Fly

SVB cuts Applied Molecular Transport to Market Perform, lowers target to $2

2y ago

AMTI

PremiumThe Fly

Applied Molecular downgraded to Market Perform from Outperform at SVB

2y ago

AMTI

PremiumThe Fly

Street Wrap: Today’s Top Upgrades, Downgrades, Initiations

2y ago

MMC

AMTI

PremiumThe FlyApplied Molecular Transport downgraded to Market Perform from Outperform at JMP Securities

2y ago

AMTI

Applied Molecular Transport downgraded to Market Perform at JMP Securities

Premium

The Fly

Applied Molecular Transport downgraded to Market Perform at JMP Securities

2y ago

AMTI

Applied Molecular Transport announces phase 2 results from Oral AMT-101 trial

Premium

The Fly

Applied Molecular Transport announces phase 2 results from Oral AMT-101 trial

2y ago

AMTI

AMTI

Trending

Indices

Stocks

ETFs